Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan · Delayed Price · Currency is TWD 80.30
-0.20 (-0.25%)
Nov 13, 2026, 1:30 PM CST
Syngen Biotech Market Cap
Syngen Biotech has a market cap or net worth of 2.18 billion as of November 13, 2026. It is the 27,903rd most valuable company in the world and the 1,573rd biggest in Taiwan. Its market cap has decreased by 37.75% in one year.
Market Cap
2.18B
Enterprise Value
2.08B
Revenue
2.05B
Global Rank
Country Rank
#1,573 Taiwan
PE Ratio
10.65
ChartMarket Cap Chart
Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 2.18B, an increase of 485.00%. That is a compound annual growth rate of 8.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 2.18B | -30.78% |
| Dec 31, 2025 | 3.14B | -8.66% |
| Dec 30, 2024 | 3.44B | -16.45% |
| Dec 29, 2023 | 4.12B | -6.17% |
| Dec 30, 2022 | 4.39B | 43.36% |
| Dec 30, 2021 | 3.06B | 4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioGend Therapeutics | 2.74B |
| Intech Biopharm | 2.74B |
| Senhwa Biosciences | 2.65B |
| Energenesis Biomedical CO.,LTD. | 2.64B |
| Chunghwa Chemical Synthesis & Biotech | 2.38B |
| GlycoNex Incorporation | 2.28B |
| Taiwan Bio Therapeutics | 2.17B |
| HeXun Biosciences | 2.09B |